1. Home
  2. PRTC vs FBIZ Comparison

PRTC vs FBIZ Comparison

Compare PRTC & FBIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • FBIZ
  • Stock Information
  • Founded
  • PRTC 2015
  • FBIZ 1909
  • Country
  • PRTC United States
  • FBIZ United States
  • Employees
  • PRTC N/A
  • FBIZ N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • FBIZ Major Banks
  • Sector
  • PRTC Health Care
  • FBIZ Finance
  • Exchange
  • PRTC Nasdaq
  • FBIZ Nasdaq
  • Market Cap
  • PRTC 388.6M
  • FBIZ 390.3M
  • IPO Year
  • PRTC N/A
  • FBIZ N/A
  • Fundamental
  • Price
  • PRTC $15.39
  • FBIZ $51.93
  • Analyst Decision
  • PRTC Buy
  • FBIZ Buy
  • Analyst Count
  • PRTC 1
  • FBIZ 3
  • Target Price
  • PRTC $45.00
  • FBIZ $58.67
  • AVG Volume (30 Days)
  • PRTC 5.0K
  • FBIZ 22.4K
  • Earning Date
  • PRTC 08-28-2025
  • FBIZ 10-23-2025
  • Dividend Yield
  • PRTC N/A
  • FBIZ 2.25%
  • EPS Growth
  • PRTC N/A
  • FBIZ 22.50
  • EPS
  • PRTC 0.20
  • FBIZ 5.60
  • Revenue
  • PRTC $6,391,000.00
  • FBIZ $150,952,000.00
  • Revenue This Year
  • PRTC N/A
  • FBIZ $17.98
  • Revenue Next Year
  • PRTC N/A
  • FBIZ $8.26
  • P/E Ratio
  • PRTC $7.29
  • FBIZ $9.23
  • Revenue Growth
  • PRTC 1265.60
  • FBIZ 8.24
  • 52 Week Low
  • PRTC $13.30
  • FBIZ $41.47
  • 52 Week High
  • PRTC $24.99
  • FBIZ $56.46
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 34.46
  • FBIZ 55.48
  • Support Level
  • PRTC $15.75
  • FBIZ $51.57
  • Resistance Level
  • PRTC $16.75
  • FBIZ $52.54
  • Average True Range (ATR)
  • PRTC 0.62
  • FBIZ 0.79
  • MACD
  • PRTC -0.14
  • FBIZ -0.02
  • Stochastic Oscillator
  • PRTC 0.00
  • FBIZ 39.37

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.

Share on Social Networks: